Physician profile
Andy J Kranenburg
NPI 1609040377
$1,615,429.33
in general payments reported to CMS, 2019-2025
18 companies · $414K in 2025
The $414K reported for 2025 was more than what 98% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134K · 2020: $67K · 2021: $92K · 2022: $220K · 2023: $309K · 2024: $379K · 2025: $414K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $957K · Consulting Fee: $108K · Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Food and Beverage: $4,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $957,391.71 |
| Consulting Fee | $108,125.00 |
| Travel and Lodging | $16,222.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,750.00 |
| Food and Beverage | $4,491.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $1,446,104.26 | 2019-2025 | |
| Medtronic, INC. | $66,681.71 | 2021-2025 | Stealthstation S8 Platform, Intellis Adaptivestim |
| Medtronic USA, INC. | $56,000.21 | 2019-2020 | |
| Boston Scientific Corporation | $28,072.81 | 2019-2025 | Wavewriter Alpha Prime 16, Coveredge 32, Bionic Navigator |
| Titan Spine, LLC | $17,843.84 | 2019 | |
| Biotronik Nro, INC. | $173.16 | 2023 | Biotronik |
| Saluda Medical Americas, INC. | $127.02 | 2025 | Evoke |
| Augmedics INC. | $102.25 | 2025 | Xvision |
| Medacta USA, INC. | $72.00 | 2023 | Myspine, Must |
| Arthrex, INC. | $64.80 | 2025 | |
| Wildwood Medical LLC | $47.99 | 2025 | |
| Nuvasive, INC. | $41.53 | 2023 | Alif |
| Surgalign Spine Technologies, INC. | $25.93 | 2021 | |
| Xtant Medical INC | $23.30 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.89 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $15.63 | 2019 | |
| Nevro Corp. | $12.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Kranenburg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.